Zoeken

The 2015 Paris Climate Agreement and the 2019 European Green Deal initiated a wave of EU policies and legislation to combat climate change and protect the environment. Achieving a green transition became a key driver of EU policies. While many pieces of legislation were being discussed or adopted, the COVID-19 pandemic and the Russian invasion of Ukraine moved the political focus to supply chain security and energy dependencies. Since then, achieving open European strategic autonomy for the EU economy ...

This analysis looks at the future of the EU and Ukraine, using a time horizon of 2035. It was launched in June 2022 as a Strategic Foresight Conversation, a few months after the Russian invasion of Ukraine on 24 February 2022. The ensuing war has drastically changed all aspects of life in Ukraine, affects the EU in many significant ways and shifted pre-war geopolitical and geo-economic paradigms. The European Council decision of 24 June 2022 to give candidate status to Ukraine and Moldova added to ...

The European Parliament launched a process of monitoring possible future risks for the EU during the COVID-19 crisis, and has developed this further during Russia's war on Ukraine. The annual 'Future Shocks' series provides up-to-date, objective, and authoritative information on global risks through a 360° survey based on risk literature from a broad range of sources. Future Shocks 2023: Anticipating and weathering the next storms discusses 15 risks related to geopolitics, climate change, health, ...

Russia's military aggression against Ukraine has brought war back to Europe, altering the security equilibrium. The war has placed Ukraine at the centre of the European Council's agenda and debates. The European Council President is in regular contact with the Ukrainian leadership, multiplying visits to Ukraine and references to the war in his speeches delivered abroad. This has also been the approach of the other two key actors in the EU's external representation: the European Commission President ...

Midway of the 2030 Agenda for Sustainable Development, the High-Level Political Forum 2023 marks a pivotal point in the achievement of the Sustainable Development Goals (SDGs). The impact of the multiple crises of the past years, as well as the interlinkages and synergies of the SDGs present both challenges and opportunities for a systemic approach towards our common objectives. For the global community not to lose the progress in this global decade of action, there is a need for the EU to take the ...

The briefing provides an overview of the key positions taken ahead of MEPC 80 with a focus on both the setting of ambitious GHG targets under the revision to the IMO GHG Strategy and the further discussion of the basket of mid- to long-term measures needed to deliver this enhanced level of ambition.

This annual report of the European Parliament's Panel for the Future of Science and Technology (STOA) for the year 2022 provides a comprehensive account of European Parliament activity in promoting understanding of and research in the fields of science and technology assessment. The STOA Panel comprises 27 Members of the European Parliament representing 11 parliamentary committees.

The 76th World Health Assembly (WHA) will take place in Geneva, Switzerland, from 21 to 30 May 2023. The WHA is the highest decision-making body of the World Health Organization (WHO), gathering annually and composed of delegations from all 194 Member States (MS). The WHA discusses and votes on the decisions and resolutions prepared by either WHO’s Executive Board (EB), Director-General or proposed by groups of MS. The Executive Board is composed of 34 individuals elected for three years, and its ...

This study provides a mapping of funds contributed by different actors for the R&D and the expansion of the production capacity of COVID-19 vaccines, with a focus on those authorised in the EU. Nine vaccines are examined. It is found that governments, mainly the US (with some not-for-profit entities) decisively supported corporate investments, either for R&D, manufacturing, or both, by nearly EUR 9 billion, i.e. on average EUR one billion of grants per vaccine, with, however, vast variance across ...

Antimicrobial resistance (AMR) is a global, multidimensional phenomenon occurring in humans, animals, and environmental ecosystems. It is the ability of microbes, e.g. bacteria, viruses, fungi and protozoa, to survive in the presence of medicines designed to kill or inactivate them (antimicrobials: antibiotics, antivirals, antifungals and antiprotozoals). At patient level, AMR hampers the effective treatment of microbial infections, leading to prolonged, severe disease and, in some cases, death. ...